Treatment with UroA significantly reduced/restored CD4+ T cell population in WT mice, but not in Cyp1a1-/- mice suggesting critical role of CYP1A1 in UroA-mediated correction of immune abnormalities in colitis. Here, CD4 is linked to colitis.